282 child-specific drugs are in the pipeline, group says

01/15/2012 | PharmaTimes (U.K.)

The biopharmaceutical industry has 282 drugs undergoing clinical development or FDA evaluation for conditions affecting the pediatric population, the Pharmaceutical Research and Manufacturers of America reported. The lineup includes therapeutic candidates for cancer, infectious diseases, genetic diseases and neurological illnesses. Researchers are also evaluating many existing drugs for use in children.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC